miRNA Sequencing and Assay Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026 Global miRNA Sequencing and Assay Market is estimated to value over USD 330 million by 2026 end and register CAGR of over 10.8% during the forecast period 2019 to 2026. Genomics is gaining recognition as a mainstream medicine owing to its capability of identifying diseases and providing genetic study-based therapies. This has increased demand for customised medicines which needs molecular-level understanding of diseases. Therefore, the global miRNA sequencing and assay market shall gain significant traction over the forecast period. Increasing research on genomics coupled with massive financial backup being provided for this sector is the major driving factors of the market. Decreasing sequencing costs is another factor responsible for the proliferation of the market. Furthermore, rising demand for target-oriented therapies increases the demand for assay and sequencing thus bolstering the market. Moreover, increasing prevalence of cancer and complexities in treatment and diagnosis of certain cancer types is anticipated to drive the global market in upcoming years. Nonetheless, rising patient awareness on precision medicine and advancements in genomics are projected to propel the market further over the forecast period. However, a lack of skilled professionals can hamper market growth significantly. Sequencing Consumables Segment is Expected to Witness Significant Market Growth The sequencing consumables segment accounted for the largest market share in 2018 and it is expected to witness similar growth trends during the forecast period. This growth can be attributed to the rising adoption of small RNA sequencing along with an increasing demand for consumables. Academic and research institutes held the largest market share in 2018 and it is expected that this segment will showcase similar market growth during the forecast period. Availability of grants for conducting research and increasing emphasis on key market players on providing miRNA sequencing serviced and products for research applications. North America is predicted to showcase significant market growth during the forecast period owing to increasing investments in sequencing development, growing research activities in RNA biology and genomics. Furthermore, high-output techniques for analysing miRNA assays and sequencing has boosted the market growth.
Key market players include Thermo Fisher Scientific, Illumina, QIAGEN, Takara Bio and NEB Request a Sample Report https://www.futurewiseresearch.com/requestsample.aspx?id=3355&page=requestsample Global miRNA Sequencing and Assay Market Segmentation: By Product ·
Sequencing Consumables
·
Library Preparation Kits
By Technology ·
Sequencing by Synthesis
·
Ion Semiconductor Sequencing
·
Sequencing by Oligonucleotide Ligation and Detection
·
Nanopore Sequencing
By End User ·
Research and Academic Institutes
·
Contract Research Organizations
By Region ·
North America
·
Europe
·
Asia Pacific
·
Middle East & Africa
·
Rest of the World
Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=3355&page=askfordiscount Competitive Landscape:
·
Tier 1 players- established companies in the market with a major market share
·
Tier 2 players
·
Emerging players which are growing rapidly
·
New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: · To provide with an exhaustive analysis on the miRNA sequencing and assay market by product, by technology, by end user and by region · To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) ·
To evaluate and forecast micro-markets and the overall market
· To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Middle East & Africa and rest of the world · To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions · Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope
1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency 1.5 Stakeholders 1.6 Limitations
2 Research Methodology 2.1 Research Approach 2.1.1 Secondary Research 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Research 2.1.2.1 Key Data From Primary Sources 2.1.2.2 Break Down of Primaries 2.1.2.3 Key Industry Insights 2.2 Market Size Estimation 2.3 Data Triangulation Approach 2.4 Assumptions for the Study
3 Executive Summary
4 Exclusive Insights 4.1 miRNA Sequencing & Assays Market Overview 4.2 miRNA Sequencing & Assays Market, By Technology (2014–2026)
4.3 North America: miRNA Sequencing & Assays Market, By Product
5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Market Drivers 5.2.1.1 Advantages of miRNA Sequencing Over Other Technologies 5.2.1.2 Increasing Research Funding for Genomics 5.2.1.3 Decreasing Cost of Sequencing 5.2.2 Market Opportunities 5.2.2.1 Increasing Focus on miRNA Biomarker Discovery 5.2.3 Market Challenges 5.2.3.1 Dearth of Skilled Professionals
6 miRNA Sequencing and Assays Market, By Product 6.2 Sequencing Consumables 6.2.1 Increasing Demand for miRNA Sequencing is Boosting the Adoption of Sequencing Consumables 6.3 Library Preparation Kits 6.3.1 Library Preparation Kits Segment to Grow at the Highest Cagr During the Forecast Period
7 miRNA Sequencing and Assays Market, By Technology 7.1 Introduction
7.2 Sequencing By Synthesis 7.2.1 Sequencing By Synthesis Segment Accounted for the Largest Market Share in 2018 7.3 Ion Semiconductor Sequencing 7.3.1 Platforms Developed Using This Technology are Low-Cost Instruments and Possess High-Throughput Capabilities 7.4 Sequencing By Oligonucleotide Ligation and Detection 7.4.1 Solid Sequencing Offers Accurate Sequencing of Short Reads 7.5 Nanopore Sequencing 7.5.1 Nanopore Sequencing Segment to Witness the Highest Growth During the Forecast Period
8 miRNA Sequencing and Assays Market, By End User 8.1 Introduction 8.2 Research and Academic Institutes 8.2.1 Research and Academic Institutes Segment to Dominate This Segment 8.3 Contract Research Organizations 8.3.1 Contract Research Organizations Such as Genomics Services Companies to Grow at Highest CAGR
9 miRNA Sequencing and Assays Market, By Region 9.1 Introduction 9.2 North America 9.2.1 US 9.2.1.1 US Dominates the North American miRNA Sequencing and Assays Market, Due to the Favorable Funding Scenario for Research and StroPlayers
9.2.2 Canada 9.2.2.1 Increase in Genomics Research to Drive the Adoption of miRNA Sequencing in Canada 9.3 Europe 9.3.1 Germany 9.3.1.1 Growth of the Genomics Market to Drive the Growth of the Market Growth 9.3.2 UK 9.3.2.1 Government Initiatives in Genomics to Drive the Market for miRNA Sequencing 9.3.3 ROE 9.4 Asia Pacific 9.5 Rest of the World
10 Competitive Landscape 10.1 Overview 10.2 Vendor Benchmarking 10.3 Competitive Leadership Mapping 10.3.1 Visionary Leaders 10.3.2 Innovators 10.3.3 Dynamic Differentiators 10.3.4 Emerging Companies 10.4 Market Ranking Analysis, 2017 10.5 Competitive Situation and Trends 10.5.1 Collaborations, Partnerships, and Agreements
10.5.2 Product Launches 10.5.3 Acquisitions
11 Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise Perspective)* 11.1 Illumina, Inc. 11.2 Thermo Fisher Scientific 11.3 Qiagen 11.4 Perkinelmer, Inc. 11.5 Takara Bio, Inc. 11.6 New England Biolabs, Inc. 11.7 Norgen Biotek Corporation 11.8 Trilink Biotechnologies 11.9 Lexogen 11.10 Oxford Nanopore Technologies
12. Assumptions and Acronyms 13. Research Methodology 14. List of Sources of Information (Primary and Secondary) Inquire further details about this report at: sales@futurewiseresearch.com
About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com